Oral-Allergy Syndrome

Although this year brought many advances in the treatment of food allergy, the FDA’s approval of omalizumab dominated our most popular coverage.

The Allergy & Asthma Network praised three major pharmaceutical companies, AstraZeneca, Boehringer Ingelheim and GSK, that announced they will enact a $35 price cap on their inhaler products.

As spring begins, patients with tree, grass and weed allergies may have to cope with oral allergy syndrome, which arises from an allergic reaction to certain fresh or raw foods, including vegetables, fruits and nuts, a specialist said.

Healio has compiled March’s most-read news in asthma and allergy.

Spring is upon us in the Northern Hemisphere, and many patients are experiencing classic “hay fever” symptoms including itch, stuffy nose, sneezing and rash as well as eye symptoms.